sunitinib,pembrolizumab,lenvatinib
merck,eisai,pfizer
['clear study', 'lenva', 'pembro']
updated results of the clear study! os is still improved in all pts treated with pembro+lenva; fewer events in the favorable risk group should be evaluated carefully. #esmo2022 #camilloguglielmoporta 
Medical Oncologist/T?bbi Onkolog
#genitourinary and #gastrointestinal cancers 
#computational oncology
Tweets for scientific purposes. Not medical advice!